CaridianBCT receives CE Mark for expanded use of Mirasol system

10/22/2008 | Pharmaceutical Business Review Online

CaridianBCT has received CE Mark approval for the expanded use of its Mirasol pathogen reduction technology system, which improves the safety of transfused blood products by reducing the levels of infectious pathogens. The approval will allow for the storage of platelets in 100% plasma or in an approved platelet additive solution.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ